ODOMZO

Novartis AG

Application Filed: 2008-04-24

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	77456621
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Novartis Pharmaceuticals Corporation
Attorney Name	Maury M. Tepper, III
Attorney Docket Number	51653
Law Office Assigned	M20
Employee Name	MULLEN, MARK TIMOTHY

Timeline

2008-04-24	Application Filed
2008-09-16	Published for Opposition
2011-01-12	Location: INTENT TO USE SECTION
2011-07-11	Abandon
2011-07-11	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Novartis AG
Address	CH 4002 Basel CH
Legal Entity Type	Corporation
Legal Entity State	CH

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Maury M. Tepper, III
Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh NC 27609

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations; Pharmaceutical preparations for the treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations

Type Code

Type

GS0051

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations; Pharmaceutical preparations for the treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2008-04-28	1 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER	2008-08-07	2 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2008-08-07	3 CNSA P:
ASSIGNED TO LIE	2008-08-14	4 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2008-08-14	5 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2008-08-27	6 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2008-09-16	7 PUBO A:Allowance for Publication
NOA MAILED - SOU REQUIRED FROM APPLICANT	2008-12-09	8 NOAM O:Outgoing Correspondence
TEAS EXTENSION RECEIVED	2009-06-08	9 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2009-06-08	10 EXT1 S:
EXTENSION 1 GRANTED	2009-06-08	11 EX1G S:
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2009-06-25	12 TCCA I:Incoming Correspondence
TEAS EXTENSION RECEIVED	2009-12-07	13 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2010-01-21	14 AITU A:Allowance for Publication
EXTENSION 2 FILED	2009-12-07	15 EXT2 S:
EXTENSION 2 GRANTED	2010-01-25	16 EX2G S:
TEAS EXTENSION RECEIVED	2010-06-07	17 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2010-06-07	18 EXT3 S:
EXTENSION 3 GRANTED	2010-06-10	19 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2010-06-11	20 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2010-12-08	21 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2010-12-08	22 EXT4 S:
EXTENSION 4 GRANTED	2011-01-12	23 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2011-01-13	24 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2011-07-11	25 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2011-07-11	26 MAB6 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
ODOMZO 86496007 4828965 Live/Registered	SUN PHARMA GLOBAL FZE 2015-01-06
ODOMZO 79102573 4089636 Dead/Cancelled	Novartis AG 2011-05-27
ODOMZO 77456621 not registered Dead/Abandoned	Novartis AG 2008-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.